# He Huang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/he-huang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,788 |
| Field | CAR-T cell therapy research |
| h-index | 71 |
| i10-index | 351 |
| Last Known Institution | Peking University |
| OpenAlex ID | https://openalex.org/A5100782959 |
| ORCID iD | https://orcid.org/0000-0002-2723-1621 |
| Works | 1,038 |

## Researcher papers

- [CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia](https://scholariq.org/papers/crispr-cas9-engineered-universal-cd19-cd22-dual-targeted-car-t-cell-therapy-for/)
- [Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study](https://scholariq.org/papers/genetically-modified-cd7-targeting-allogeneic-car-t-cell-therapy-with-enhanced/)

## Researcher topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)

## Researcher university

- [Peking University](https://scholariq.org/institutions/peking-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.